ArticleJournal of cancer prevention2018

Plasma Adropin as a Potential Marker Predicting Obesity and Obesity-associated Cancer in Korean Patients With Type 2 Diabetes Mellitus.

Ha-Neul Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.